My Tinnitus Persists: Transient or Permanent? When to Intervene?

Tinnitus — perception of sound in ear or head without external source. Mostly subjective (only patient hears) — 15-20% of adults at some point; 2-3% significantly affects quality of life.

Duration classification: (1) Acute — <3 months; mostly self-resolves with cause; (2) Subacute — 3-6 months; transition; (3) Chronic — >6 months (some guidelines use 3 months); may be permanent but habituation targeted.

Severity + distress classification (Tinnitus Functional Index TFI or THI): mild (no impact), moderate (occasionally distressing), severe (intense distress + sleep/work/social impact), incapacitating (depression + rare suicidal ideation).

Subjective vs objective: subjective (99% — only patient; auditory nerve + central pathway activity); objective (rare — examiner can hear; vascular — pulsatile, myoclonus — rhythmic muscle, palatal). Objective always requires cause search (usually treatable vascular or muscle).

Subtypes: tonal (pure tone — usually high-pitched whistle), noise (white noise — low), pulsatile (heartbeat rhythm), myoclonic (click or tap), vibratory (earth-shaking).

Causes (in decreasing incidence):

• Hearing loss (most common — 80%+ association): age-related (presbycusis), noise-induced, ototoxic, congenital, sudden.

• Noise — acute (concert, firearm, blast, loud personal headphone); chronic occupational (construction, factory, military, musician).

• Eustachian tube dysfunction / middle-ear effusion — with nasal obstruction.

• Acoustic trauma — barotrauma (flight, diving).

• Drugs (ototoxicity): aminoglycoside antibiotic (gentamicin, streptomycin), chemotherapy (cisplatin, carboplatin), salicylate (high-dose aspirin), loop diuretic (high-dose furosemide), quinine, antimalarial.

• Vascular: hypertension, atherosclerosis, angioma, AVM (arteriovenous malformation), carotid stenosis, glomus tympanicum/jugulare tumour — pulsatile.

• Acoustic neuroma (vestibular schwannoma): unilateral progressive hearing loss + tinnitus + sometimes vertigo + balance.

• Méniere's disease: episodic vertigo + tinnitus + fluctuating hearing loss + fullness.

• TMJ (temporomandibular joint) disorder: uni-/bilateral tinnitus + jaw pain + clenching.

• Cervical spine problems (whiplash): rarely tinnitus.

• Anxiety-depression: may trigger OR result; bidirectional relationship.

• Otosclerosis: stapes fixation → conductive hearing loss + tinnitus (classic young woman).

• Sinusitis + nasal obstruction: Eustachian blockage → middle-ear pressure changes → tinnitus.

• Caffeine, nicotine, alcohol excess: tinnitus modulators (increase in some).

• Stress + fatigue: tinnitus amplifiers.

• Idiopathic: no definite cause (20-30%). Related service: our otology and hearing centre.

Tinnitus is usually not urgent, but some clinical combinations need fast evaluation and treatment.

SUDDEN hearing loss + tinnitus (SSNHL): unilateral hearing loss developing within 72h; tinnitus and fullness accompany. Causes: viral cochleitis, autoimmune inner ear, vascular (microvascular occlusion), rare acoustic neuroma. Treatment: high-dose oral steroid (prednisolone 1 mg/kg/day × 14 days) + intratympanic steroid injection (3-5 spaced doses) + hyperbaric oxygen (selected cases). Effect: 30-60% hearing recovery if started within 2 weeks; 10-20% if delayed. Urgent ENT — within hours.

PULSATILE tinnitus: heartbeat-rhythmic (objective or subjective) — vascular or tumour suspicion. Causes: hypertension, atherosclerosis, carotid stenosis, AVM, glomus tympanicum/jugulare tumour, sigmoid sinus diverticulum, idiopathic intracranial hypertension (pseudotumour cerebri — especially obese young woman), severe anaemia (high cardiac output). Urgent: ENT + neurology + radiology; MR + MR-angio or CT-angio + echocardiogram + duplex ultrasound; angiography in selected cases. Treatment is cause-directed.

Unilateral tinnitus + hearing loss + vertigo: ACOUSTIC NEUROMA (vestibular schwannoma) suspicion. Cause: benign VIII cranial nerve Schwann cell tumour; cerebellopontine angle location. Typical: unilateral slow progressive hearing loss (high-frequency dominant), tinnitus (high tonal), vertigo (mild imbalance usually), VII cranial nerve (facial palsy — late), V cranial nerve (facial numbness — late). Diagnosis: MR + contrast (gold standard). Treatment: observation (small + slow-growing), stereotactic radiosurgery (Gamma Knife, CyberKnife), microsurgical resection (large). Early diagnosis preserves hearing + reduces complications.

New-onset tinnitus + ototoxic drug history: aminoglycoside (IV gentamicin), cisplatin, high-dose salicylate, loop diuretic. Drug change or dose adjustment coordinated by ENT and prescriber. Reversibility — some (especially salicylate), permanent in others.

Acute middle-ear infection + tinnitus + pain + fever: tympanic membrane exam; acute otitis media. Treatment: antibiotic (adult amoxicillin/clavulanate 7-10 days; child as indicated), analgesia. Tinnitus resolves with effusion + inflammation.

Post-traumatic tinnitus + head injury: temporal bone fracture, perilymph fistula, otoconial displacement, middle-ear injury. Urgent ENT + temporal CT + audiometry.

Méniere's attack: vertigo + tinnitus + fluctuating hearing loss + fullness; acute management (anti-vertigo, anti-emetic), long-term sodium restriction + diuretic + intratympanic corticosteroid or surgery.

General rule: tinnitus + ADDITIONAL symptom (hearing loss, vertigo, sound pain, fever, neurologic finding) → urgent ENT within 24-72h. Isolated tinnitus monitor up to 3 months + medical/behavioural treatment.

Tinnitus diagnostic aims: (a) predict persistence/transience, (b) identify treatable underlying cause, (c) manage comorbid problems (hearing loss, vertigo, anxiety), (d) personalised care plan.

ENT office (visit 1): detailed history (duration, pattern, intensity, triggers, associated symptoms, drugs, noise exposure, family, systemic); examination (otoscopy — external ear + tympanic membrane, nasal cavity + nasopharyngeal endoscopy, neck, TMJ palpation, brief cranial nerve exam); Weber + Rinne tests (conductive/sensorineural rough screen).

Audiometry: standard. Air-conduction thresholds (250-8000 Hz) + bone-conduction + masking. Hearing loss type (conductive, sensorineural, mixed) + degree + frequency pattern. High-frequency (8-16 kHz) extended audiometry — see hidden damage (especially early noise damage). Most chronic tinnitus patients show some degree of hearing loss.

Tympanometry: middle-ear pressure + tympanic membrane mobility. Pathologies: effusion (Type B), Eustachian dysfunction (Type C), ossicular discontinuity (high peak), otosclerosis (low amplitude).

Acoustic reflex: cranial nerves VIII + VII + retrocochlear screen.

OAE (otoacoustic emissions): cochlear outer hair cell function — early damage indicator (noise, ototoxicity).

ABR (auditory brainstem response): retrocochlear + brainstem auditory pathway. Acoustic neuroma suspicion (unilateral tinnitus + hearing loss), brainstem pathology.

MR + contrast: unilateral tinnitus, acoustic neuroma suspicion, pulsatile tinnitus, brainstem symptoms. Standard early step in algorithm.

Temporal bone CT: trauma, otosclerosis, ossicular damage, cholesteatoma, glomus tumour bone involvement.

MR-angio / CT-angio / classic angio: pulsatile tinnitus, vascular lesion suspicion.

Lab: haematocrit + haemoglobin (anaemia), TSH (thyroid), B12 + folate (neural), HbA1c (diabetes — microvascular), lipid profile (vascular risk), thyroid + rheumatologic panel (autoimmune cochleitis suspicion), VDRL/RPR (syphilis — ototoxic), Lyme serology (rare neuroLyme).

Tinnitus impact questionnaire: THI (Tinnitus Handicap Inventory — 25 items, 0-100) or TFI (Tinnitus Functional Index). Compare pre-/post-treatment. Tinnitus pitch + loudness matching (frequency + level — masking + sound therapy parameter set).

Psychological assessment: anxiety (GAD-7), depression (PHQ-9) screening. Chronic tinnitus + psychological distress association high; needs combined care.

Dental consult: TMJ + bruxism suspicion.

Multidisciplinary team: ENT (otology specialist), audiologist, psychologist (CBT-trained), neurology (if needed), cardiology (pulsatile + vascular), dentist (TMJ). More detail: tinnitus page.

The chronic-tinnitus treatment goal is NOT silencing but habituation — reducing the degree to which it limits quality of life. Because in permanent (especially sensorineural hearing loss-associated) tinnitus cochlear damage is permanent; physically silencing is often impossible. Goal: a point where tinnitus does not capture attention and does not disturb sleep + daily activity.

Cause-specific treatments:

(A) Hearing loss association: hearing aid — supra-threshold stimulation masks tinnitus + rehabilitates central auditory pathways. 50-60% have meaningful reduction. Some hearing aids have "tinnitus masking" (integrated sound therapy program). Cochlear implant — severe hearing loss + tinnitus; 80%+ implant recipients report reduction.

(B) Eustachian dysfunction / effusion: medical (saline + intranasal steroid) → if no response, tympanostomy tube.

(C) Otosclerosis: stapedectomy (conductive loss improves; tinnitus 70% reduction).

(D) Acoustic neuroma: observation, stereotactic radiosurgery, microsurgical resection (by size).

(E) Méniere's: sodium restriction + diuretic (hydrochlorothiazide) + intratympanic steroid; refractory — labyrinthectomy, vestibular neurectomy.

(F) Vascular: hypertension control, carotid stenosis stenting, AVM embolisation, glomus tumour surgery/radiotherapy.

(G) TMJ: dentist + occlusal splint + physiotherapy + Botox masseter (refractory).

(H) Drug ototoxicity: drug change / dose adjust (with prescriber coordination).

Habituation treatments for idiopathic or permanent sensorineural tinnitus:

(1) Tinnitus Retraining Therapy (TRT): Pawel Jastreboff (1990) tinnitus + hearing rehabilitation programme. Two components: (a) Education (counselling) — tinnitus mechanism, brain habituation, "no danger" message; (b) Sound therapy — low-level background sound (white noise, nature sound, music) reduces perception + attention. 12-18 month course. 70-80% meaningful reduction.

(2) Cognitive Behavioural Therapy (CBT): 8-16 sessions with clinical psychologist. Goal — change reactive thoughts + emotions (anxiety, helplessness, fear) and behaviour (avoidance, constant monitoring), not the tinnitus itself. Strongest evidence (Cochrane meta-analysis).

(3) Sound therapy + masking: ambient sound masks tinnitus (short-term) or overlays (long-term — TRT approach). Devices: tinnitus masker, hybrid hearing aid+masker, digital apps (smartphone — Resound, Widex, Phonak), sound generators. Patient-chosen sound (pink noise, ocean, music) setting.

(4) Mindfulness + meditation: effective especially with anxiety.

(5) Acupuncture, hypnosis, biofeedback: helpful for some; limited scientific evidence.

(6) Drug treatment: NO approved drug for primary tinnitus. Antidepressants + anxiolytics for comorbid anxiety-depression (sertraline, escitalopram, mirtazapine, alprazolam — short-term). Melatonin (sleep). Magnesium, zinc, B12 supplementation — limited evidence. Ginkgo biloba — Cochrane meta-analysis no effect, but some patient experience positive.

(7) Emerging treatments: bimodal stimulation (Lenire — FDA approved 2020; sound + tongue electrical stimulation), neuromodulation (TMS transcranial magnetic stimulation), cochlear implant in permanent hearing loss + tinnitus.

Practical patient advice:

• Avoid silence — low-level background sound (fan, music, nature) at bedtime, in quiet rooms;

• Reduce noise exposure — hearing protection, avoid loud venues;

• Stress management — yoga, meditation, physical exercise;

• Sleep hygiene — regular schedule, less alcohol/caffeine, less screen light;

• Diet — moderate salt (restrict if Méniere suspected), moderate caffeine, stop smoking, less alcohol;

• Anxiety-depression treatment if needed;

• Patient support groups (online forums — sharing + information);

• Tinnitus diary — trigger identification.

Prof. Dr. Hasan Ahmet Özdoğan clinic approach: ENT otology + multidisciplinary team (audiologist, CBT psychologist, dentist) + advanced testing (MR + ABR + extended audiometry + OAE) + individualised protocol + long-term follow-up (3, 6, 12 months). Related: tinnitus-hyperacusis relationship (our prior post), workplace noise-induced hearing loss prevention (our prior post), Méniere's diagnosis-treatment (our prior post). Related reading: our patient testimonials.